Expert Opin Pharmacother 2017 Feb;18(3):325-326

Upfront nilotinib therapy among patients with chronic myeloid leukemia in chronic phase.

Eskazan AE1.
Chronic myeloid leukemia; frontline treatment; nilotinib
ukemia; frontline treatment; nilotinib